Amicus Therapeutics is a global, patient-dedicated biotechnology company focused on discovering, developing, and delivering high-quality medicines for people living with rare metabolic diseases.
The Vice President of Global Drug Safety is a senior leader responsible for defining and executing the company’s global pharmacovigilance strategy, with a primary focus on post-approval safety and risk management. Reporting to the SVP of Clinical Development and Safety, this role blends strategic vision with operational leadership across safety surveillance activities, ensuring regulatory compliance, patient protection, and driving innovation in safety science throughout the post-approval lifecycle.
This critical position plays a pivotal role in advancing the company’s global pharmacovigilance strategy and safeguarding patient safety worldwide. As a key member of the governance leadership team, the Vice President contributes to long-term ...